INSIGHTS ON PHARMACEUTICAL INSPECTION

• What Is The Position Of Regulatory Authorities On PUPSIT?

  PUPSIT and other integrity testing methods are crucial for manufacturers to reduce contamination risks and ensure drug product safety. Learn how your company can adhere to updated regulatory guidelines.

• OEE And Product Inspection

  Explore the calculation of Overall Equipment Effectiveness (OEE) and the impact of product inspection equipment on OEE in the pharmaceutical industry.

• Mastering Ethylene Oxide Sterilization: Your Comprehensive Field Guide

  Whether you're refining existing protocols or developing new ones, this guide serves as a valuable resource for ensuring safe, effective, and compliant sterilization outcomes.

• Qualicaps Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And Packaging

  Explore how a new capsule inspection system helps manufacturers overcome labor shortages, increase throughput, and maintain quality while meeting global compliance standards.

• What Pharma And Biopharma Should Know About Container Closure Integrity

  8/1/2024

  Explore high voltage leak detection, headspace analysis, and vacuum and pressure decay as applied in pharmaceutical manufacturing.

• Supporting GLP-1 And Peptides With Integrated Solutions

  9/30/2025

  Accelerate GLP-1 and peptide therapy development with integrated drug containment, delivery, machinery, and analytics for reliable combination product performance.

• Visual Inspection Of Advanced Therapy Medicinal Products

  9/2/2025

  Discover how expert database systems for inspection defect management and control help cell and gene therapies meet the requirements of USP-790 to assure they are essentially free from particulate matter.

• Pharma Product Inspection At Pack Expo 2023

  8/15/2025

  Learn more about specialized inspection equipment for pharmaceutical products, including an X-ray for blister packs and a high-speed metal detector for tablets.

• Risk Management Across The Pharmaceutical Product Lifecycle

  1/5/2026

  Managing risk throughout the pharmaceutical lifecycle requires proactive strategies. Explore advanced detection methods and rigorous sampling that ensure product integrity.